Download Files:
Products Details
Product Description
– Lp-PLA2-IN-12 (compound 19) is an Lp-PLA2 inhibitor. Lp-PLA2-IN-12 can be used for the study of neurodegenerative related diseases such as Alzheimer’s disease (AD), glaucoma, age-related macular degeneration (AMD), or cardiovascular disease including atherosclerosis[1].
Web ID
– HY-153183
Shipping
– Room temperature
Molecular Formula
– C24H23F2N5O3
References
– [1]Xiao Qiong, et al. Tetracyclic pyrimidinone compounds, preparation method, composition and application thereof. Patent, CN112574221A.
CAS Number
– 2637485-14-2
Molecular Weight
– 467.47
SMILES
– O=C1N2C[C@]3(CC[C@H]4CCC3)N4C2=CC(OCC(C=C5F)=CC(F)=C5OC(C=N6)=CN=C6C)=N1
Clinical Information
– No Development Reported
Research Area
– Neurological Disease; Cardiovascular Disease
Solubility
– 10 mM in DMSO
Target
– Phospholipase
Pathway
– Metabolic Enzyme/Protease
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
